GL Ventures, LAV co-lead $50m Series A funding in vision therapy firm Elumninex

GL Ventures, LAV co-lead $50m Series A funding in vision therapy firm Elumninex

24 November, 2020

Elumninex Biosciences GL Ventures Lilly Asia Ventures (LAV)

Printed by Unregistered user on Sat, 26 Jul 2025 15:47:34 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Venture Capital

HK-listed Lee’s Pharmaceutical unit nets $145m co-led by Hillhouse, TPG Asia

Venture Capital

Chinese biotech EdiGene raises $15m pre-Series B led by Lilly Asia Ventures

Read more from Greater China

Hong Kong IPO boom triggers price war among banks

Chinese e-commerce giants defend ‘instant retail’ strategy despite state pressure